Market cap
$357.3B
Price as of
2026-10-29
Latest filing
8-K
Alerts
8
Price$81.67 +12.37% 3M daily closessample
85.2872.08
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 20INS
- Oct 13INS
- Oct 06INS
- Oct 01INS
- Sep 24INS
- Sep 17INS
- Sep 09INS
- Sep 04INS
Company facts
SEC EDGAR registration- Name
- C4 Therapeutics, Inc.
- Sector
- Biotechnology
- Industry
- Biotechnology
- Smart-money score
- -31sample, -100 to +100
- Reporting currency
- USD
Who is positioning in CCCC
sample- Insiders
- 15 insider transactions over 90 days, net selling, $699.6M
- Congress
- 1 members traded over 90 days
- Institutions · 13F
- 9 funds hold $3.3B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$21.7B +22.2% y/y
Q4 2024Q3 2026
Inventory$13.1B +13.7% y/y
Q4 2024Q3 2026
Accounts receivable$9.2B +6.2% y/y
Q4 2024Q3 2026
Total debt$25.6B +12.4% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $100.0B -9.8% 3M
- Sample peer B
- $207.2B +8.3% 3M
- Sample peer C
- $355.9B +13.3% 3M
- Sample peer D
- $216.5B -5.8% 3M
- Sample peer E
- $273.9B +8.5% 3M